Literature DB >> 9276706

Resection of liver metastases of colorectal carcinoma.

S Nakamura1, S Suzuki, S Baba.   

Abstract

Hepatic metastasis of colorectal cancer is a life-threatening prognostic factor. The present review revealed that hepatic resection is the best treatment modality, although the overall survival rate after hepatectomy for metastatic colorectal cancer is still low (20-40%). Various prognostic factors analyzed by many authors are controversial. The number of hepatic metastases and the surgical margin were the most important prognostic factors, as seen in 10 papers previously reported including our data. A clear surgical margin is achievable, but the prognosis of patients with four or more metastatic nodules in the liver remains poor. Repeat hepatectomy is also evaluated and is believed by many surgeons to have acceptable mortality. It improved survival to a certain extent. Analysis of the biologic characteristics of primary and metastatic tumors is extremely important and is urgently indicated.

Entities:  

Mesh:

Year:  1997        PMID: 9276706     DOI: 10.1007/s002689900300

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  Hepatic resection for metastatic tumors from gastric cancer.

Authors:  Keiichi Okano; Takashi Maeba; Ken Ishimura; Yukihiko Karasawa; Fuminori Goda; Hisao Wakabayashi; Hisashi Usuki; Hajime Maeta
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

2.  Patterns of surveillance following curative intent therapy for gastroesophageal cancer.

Authors:  Renata D Peixoto; Howard J Lim; Haerin Kim; Ahmad Abdullah; Winson Y Cheung
Journal:  J Gastrointest Cancer       Date:  2014-09

3.  Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy.

Authors:  R Konopke; S Kersting; H Bergert; A Bloomenthal; J Gastmeier; H D Saeger; A Bunk
Journal:  Int J Colorectal Dis       Date:  2006-05-30       Impact factor: 2.571

Review 4.  Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.

Authors:  G Scott Gazelle; M G Myriam Hunink; Karen M Kuntz; Pamela M McMahon; Elkan F Halpern; Molly Beinfeld; Jessica S Lester; Kenneth K Tanabe; Milton C Weinstein
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

5.  Detection of hepatic metastases using dual-time-point FDG PET/CT scans in patients with colorectal cancer.

Authors:  Jeong Won Lee; Seok-Ki Kim; Sang Mi Lee; Seung Hwan Moon; Tae-Sung Kim
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

6.  Detection of liver metastases under 2 cm: comparison of different acquisition protocols in four row multidetector-CT (MDCT).

Authors:  Amina Abdelmoumene; Patrick Chevallier; Marc Chalaron; Frédéric Schneider; Francis R Verdun; Phillipe Frascarolo; Reto Meuli; Pierre Schnyder; Alban Denys
Journal:  Eur Radiol       Date:  2005-05-03       Impact factor: 5.315

7.  Dual-time-point FDG-PET/CT for the detection of hepatic metastases.

Authors:  Albert Dirisamer; Benjamin S Halpern; Wolfgang Schima; Martin Heinisch; Florian Wolf; Mohsen Beheshti; Franz Dirisamer; Michael Weber; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2008-08-16       Impact factor: 3.488

Review 8.  Non-invasive diagnostic imaging of colorectal liver metastases.

Authors:  Pier Paolo Mainenti; Federica Romano; Laura Pizzuti; Sabrina Segreto; Giovanni Storto; Lorenzo Mannelli; Massimo Imbriaco; Luigi Camera; Simone Maurea
Journal:  World J Radiol       Date:  2015-07-28

9.  Liver resection for breast cancer metastasis: does it improve survival?

Authors:  Jean Lubrano; Horace Roman; Sophie Tarrab; Benoit Resch; Loïc Marpeau; Michel Scotté
Journal:  Surg Today       Date:  2008-03-27       Impact factor: 2.549

10.  Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation.

Authors:  Anna Maria Ierardi; Chiara Floridi; Federico Fontana; Claudio Chini; Francesca Giorlando; Filippo Piacentino; Luca Brunese; Graziella Pinotti; Alessandro Bacuzzi; Gianpaolo Carrafiello
Journal:  Radiol Med       Date:  2013-07-20       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.